Low Dose Naltrexone
Low-Dose Naltrexone
LDN is recognized as a highly effective therapy for conditions ranging from cancer to autoimmune disorders to autism.
What is LDN?
Low-dose Naltrexone (LDN) is a safe, inexpensive, yet underused drug that is extremely beneficial for patients with any condition marked by immune system dysfunction. Naltrexone has been used in 50 mg doses for decades to help patients recover from addiction to alcohol, heroin, and other opiate drugs. However, in the 1980s, New York City physician Bernard Bihari, MD, discovered that very low doses of Naltrexone had profound effects on the immune system.
He began giving patients with AIDS 1.5 to 4.5 mg of LDN at bedtime, and they had remarkable improvements. He then tried it with patients suffering with cancer and autoimmune disorders, with equally good results. Today, LDN is recognized as a highly effective therapy for conditions ranging from cancer to autoimmune disorders to autism.
How Does LDN Work?
LDN works by boosting levels of endorphins. Endorphins are peptides produced in the brain and adrenal glands that are best known for relieving pain and enhancing sense of well-being—they’re responsible for the “runner’s high” brought on by strenuous exercise. But these natural peptides are also powerful modulators of the immune system.
When LDN is taken at bedtime, it attaches to opioid receptors and temporarily blocks endorphins from attaching. This signals the body to increase production of endorphins, which help orchestrate the activity of stem cells, macrophages, natural killer cells, T and B cells, and other immune cells. As a result, LDN enhances the body’s ability to fight disease.
| What Conditions Benefit From Low-Dose Naltrexone? | ||
| ALS (Lou Gehrig’s disease) | Alzheimer’s disease | Ankylosing spondylitis |
| Autism | Celiac disease | Chronic fatigue syndrome |
| Crohn’s disease | Emphysema (COPD) | Endometriosis |
| Fibromyalgia | HIV/AIDS | Inflammatory bowel disease |
| Lupus | Multiple sclerosis (MS) | Parkinson’s disease |
| Psoriasis | Rheumatoid arthritis | Sarcoidosis |
| Scleroderma | Ulcerative colitis | |
| Cancer | ||
| Bladder cancer | Breast cancer | Colorectal cancer |
| Glioblastoma | Liver cancer | Lung cancer (non-small cell) |
| Lymphocytic leukemia | Lymphoma | Malignant melanoma |
| Multiple myeloma | Neuroblastoma | Ovarian cancer |
| Pancreatic cancer | Prostate cancer | Renal cell carcinoma |
| Throat cancer | Uterine cancer | |
For More Information Contact Us
To schedule an appointment at the DaSilva Institute, contact a Patient Services Representative at (888) 832-7458 or click Become a New Patient.
.
 |
|
